← All companies

LTRN

Lantern Pharma Inc.

LTRN Nasdaq Pharmaceutical Preparations EDGAR ↗

$2.61

-0.04 -1.51%

Key statistics

from XBRL data in SEC filings

Market cap

$29.5M

Revenue (TTM)

—

Net income (TTM)

-$15.9M

EPS (TTM)

$-1.45

P/E ratio

—

Dividend yield

—

Free cash flow

-$15.7M

Cash

$4.92M

Total assets

$7.22M

Gross margin

—

52-week range

$1.11 – $5.74

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure Aug 3, 2026 8-K Regulation FD disclosure Jun 2, 2026 8-K Results of operations (earnings release) May 15, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events May 14, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Regulation FD disclosure Apr 10, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 30, 2026 8-K Regulation FD disclosure Jan 23, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Shareholder vote results Sep 23, 2025 8-K Results of operations (earnings release) Aug 13, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Director or officer change; Amended charter or bylaws Jul 29, 2025 8-K Entered a material agreement Jul 3, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 15, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 27, 2025 8-K Director or officer change Jan 10, 2025 8-K Regulation FD disclosure Nov 8, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 8, 2024 8-K Shareholder vote results Jun 17, 2024 8-K Amended charter or bylaws May 24, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 9, 2024 10-K Fiscal year ended 2023-12-31 Mar 18, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Mar 18, 2024 8-K Director or officer change Dec 29, 2023 8-K Entered a material agreement Nov 24, 2023 10-Q Quarter ended 2023-09-30 Nov 8, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Nov 8, 2023 8-K Other events Oct 20, 2023 10-Q Quarter ended 2023-06-30 Aug 9, 2023